Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Nature Communications|August 21, 2025
LYMTACs:chimeric small molecules repurpose lysosomal membrane proteins for target protein relocalization and degradationDhanusha A Nalawansha, Georgios Mazis, Gitte Husemoen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 28, 2016
Practical and Robust Identification of Molecular Subtypes in Colorectal Cancer by ImmunohistochemistryAnne Trinh, Kari Trumpi, Felipe De Sousa E Melo, et al.
Cell Stem Cell|November 8, 2011
Methylation of cancer-stem-cell-associated Wnt target genes predicts poor prognosis in colorectal cancer patientsFelipe de Sousa E Melo, Selcuk Colak, Joyce Buikhuisen, et al.
Nature|June 29, 2018
OTULIN limits cell death and inflammation by deubiquitinating LUBACKlaus Heger, Katherine E Wickliffe, Ada Ndoja, et al.
Nature Medicine|April 16, 2013
Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesionsFelipe De Sousa E Melo, Xin Wang, Marnix Jansen, et al.
Nature Communications|September 23, 2023
Tumor-intrinsic expression of the autophagy gene Atg16l1 suppresses anti-tumor immunity in colorectal cancerLucia Taraborrelli, Yasin Şenbabaoğlu, Lifen Wang, et al.
Science Advances|May 22, 2026
Tumor-targeted bispecific antibodies effectively inhibit oncogenic pathways while minimizing toxicityYvonne T Kschonsak, Wei-Ching Liang, Joyce Chan, et al.
Nature Cell Biology|September 5, 2018
Stem cell functionality is microenvironmentally defined during tumour expansion and therapy response in colon cancerKristiaan J Lenos, Daniël M Miedema, Sophie C Lodestijn, et al.
Nature|September 21, 2022
Antibody targeting of E3 ubiquitin ligases for receptor degradationHadir Marei, Wen-Ting K Tsai, Yee-Seir Kee, et al.
Nature Medicine|October 13, 2015
The consensus molecular subtypes of colorectal cancerJustin Guinney, Rodrigo Dienstmann, Xin Wang, et al.
Pageof 5